The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global On-Body Delivery System (OBDS) Market Research Report 2024
Synopsis
Global On-Body Delivery System (OBDS) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole On-Body Delivery System (OBDS) market research.
The on-body delivery system (OBDS) market is changing rapidly, and it has become clear that OBDS are critical to the delivery of some new drugs in development. The OBDS market is relatively young, which lends itself to exciting innovations and high potential growth rate. Many companies have products that are still in development and have not yet been commercialized.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global On-Body Delivery System (OBDS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
West Pharmaceutical Services
Gerresheimer
Stevanato Group
Enable Injections
Insulet
Ypsomed
Bexson
Nemera
BD Medical
Segment by Type
Push Drug Out Of Container
Pull Drug Out Of Container
Segment by Application
Diabetes
Parkinson'S Disease
Cancer
Cardiovascular Diseases
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The On-Body Delivery System (OBDS) report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global On-Body Delivery System (OBDS) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole On-Body Delivery System (OBDS) market research.
The on-body delivery system (OBDS) market is changing rapidly, and it has become clear that OBDS are critical to the delivery of some new drugs in development. The OBDS market is relatively young, which lends itself to exciting innovations and high potential growth rate. Many companies have products that are still in development and have not yet been commercialized.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global On-Body Delivery System (OBDS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
West Pharmaceutical Services
Gerresheimer
Stevanato Group
Enable Injections
Insulet
Ypsomed
Bexson
Nemera
BD Medical
Segment by Type
Push Drug Out Of Container
Pull Drug Out Of Container
Segment by Application
Diabetes
Parkinson'S Disease
Cancer
Cardiovascular Diseases
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The On-Body Delivery System (OBDS) report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 On-Body Delivery System (OBDS) Market Overview
1.1 Product Overview and Scope of On-Body Delivery System (OBDS)
1.2 On-Body Delivery System (OBDS) Segment by Type
1.2.1 Global On-Body Delivery System (OBDS) Market Value Comparison by Type (2023-2029)
1.2.2 Push Drug Out Of Container
1.2.3 Pull Drug Out Of Container
1.3 On-Body Delivery System (OBDS) Segment by Application
1.3.1 Global On-Body Delivery System (OBDS) Market Value by Application: (2023-2029)
1.3.2 Diabetes
1.3.3 Parkinson'S Disease
1.3.4 Cancer
1.3.5 Cardiovascular Diseases
1.3.6 Other
1.4 Global On-Body Delivery System (OBDS) Market Size Estimates and Forecasts
1.4.1 Global On-Body Delivery System (OBDS) Revenue 2018-2029
1.4.2 Global On-Body Delivery System (OBDS) Sales 2018-2029
1.4.3 Global On-Body Delivery System (OBDS) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 On-Body Delivery System (OBDS) Market Competition by Manufacturers
2.1 Global On-Body Delivery System (OBDS) Sales Market Share by Manufacturers (2018-2023)
2.2 Global On-Body Delivery System (OBDS) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global On-Body Delivery System (OBDS) Average Price by Manufacturers (2018-2023)
2.4 Global On-Body Delivery System (OBDS) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of On-Body Delivery System (OBDS), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of On-Body Delivery System (OBDS), Product Type & Application
2.7 On-Body Delivery System (OBDS) Market Competitive Situation and Trends
2.7.1 On-Body Delivery System (OBDS) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest On-Body Delivery System (OBDS) Players Market Share by Revenue
2.7.3 Global On-Body Delivery System (OBDS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 On-Body Delivery System (OBDS) Retrospective Market Scenario by Region
3.1 Global On-Body Delivery System (OBDS) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global On-Body Delivery System (OBDS) Global On-Body Delivery System (OBDS) Sales by Region: 2018-2029
3.2.1 Global On-Body Delivery System (OBDS) Sales by Region: 2018-2023
3.2.2 Global On-Body Delivery System (OBDS) Sales by Region: 2024-2029
3.3 Global On-Body Delivery System (OBDS) Global On-Body Delivery System (OBDS) Revenue by Region: 2018-2029
3.3.1 Global On-Body Delivery System (OBDS) Revenue by Region: 2018-2023
3.3.2 Global On-Body Delivery System (OBDS) Revenue by Region: 2024-2029
3.4 North America On-Body Delivery System (OBDS) Market Facts & Figures by Country
3.4.1 North America On-Body Delivery System (OBDS) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America On-Body Delivery System (OBDS) Sales by Country (2018-2029)
3.4.3 North America On-Body Delivery System (OBDS) Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe On-Body Delivery System (OBDS) Market Facts & Figures by Country
3.5.1 Europe On-Body Delivery System (OBDS) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe On-Body Delivery System (OBDS) Sales by Country (2018-2029)
3.5.3 Europe On-Body Delivery System (OBDS) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific On-Body Delivery System (OBDS) Market Facts & Figures by Country
3.6.1 Asia Pacific On-Body Delivery System (OBDS) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific On-Body Delivery System (OBDS) Sales by Country (2018-2029)
3.6.3 Asia Pacific On-Body Delivery System (OBDS) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America On-Body Delivery System (OBDS) Market Facts & Figures by Country
3.7.1 Latin America On-Body Delivery System (OBDS) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America On-Body Delivery System (OBDS) Sales by Country (2018-2029)
3.7.3 Latin America On-Body Delivery System (OBDS) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa On-Body Delivery System (OBDS) Market Facts & Figures by Country
3.8.1 Middle East and Africa On-Body Delivery System (OBDS) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa On-Body Delivery System (OBDS) Sales by Country (2018-2029)
3.8.3 Middle East and Africa On-Body Delivery System (OBDS) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global On-Body Delivery System (OBDS) Sales by Type (2018-2029)
4.1.1 Global On-Body Delivery System (OBDS) Sales by Type (2018-2023)
4.1.2 Global On-Body Delivery System (OBDS) Sales by Type (2024-2029)
4.1.3 Global On-Body Delivery System (OBDS) Sales Market Share by Type (2018-2029)
4.2 Global On-Body Delivery System (OBDS) Revenue by Type (2018-2029)
4.2.1 Global On-Body Delivery System (OBDS) Revenue by Type (2018-2023)
4.2.2 Global On-Body Delivery System (OBDS) Revenue by Type (2024-2029)
4.2.3 Global On-Body Delivery System (OBDS) Revenue Market Share by Type (2018-2029)
4.3 Global On-Body Delivery System (OBDS) Price by Type (2018-2029)
5 Segment by Application
5.1 Global On-Body Delivery System (OBDS) Sales by Application (2018-2029)
5.1.1 Global On-Body Delivery System (OBDS) Sales by Application (2018-2023)
5.1.2 Global On-Body Delivery System (OBDS) Sales by Application (2024-2029)
5.1.3 Global On-Body Delivery System (OBDS) Sales Market Share by Application (2018-2029)
5.2 Global On-Body Delivery System (OBDS) Revenue by Application (2018-2029)
5.2.1 Global On-Body Delivery System (OBDS) Revenue by Application (2018-2023)
5.2.2 Global On-Body Delivery System (OBDS) Revenue by Application (2024-2029)
5.2.3 Global On-Body Delivery System (OBDS) Revenue Market Share by Application (2018-2029)
5.3 Global On-Body Delivery System (OBDS) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 West Pharmaceutical Services
6.1.1 West Pharmaceutical Services Corporation Information
6.1.2 West Pharmaceutical Services Description and Business Overview
6.1.3 West Pharmaceutical Services On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 West Pharmaceutical Services On-Body Delivery System (OBDS) Product Portfolio
6.1.5 West Pharmaceutical Services Recent Developments/Updates
6.2 Gerresheimer
6.2.1 Gerresheimer Corporation Information
6.2.2 Gerresheimer Description and Business Overview
6.2.3 Gerresheimer On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Gerresheimer On-Body Delivery System (OBDS) Product Portfolio
6.2.5 Gerresheimer Recent Developments/Updates
6.3 Stevanato Group
6.3.1 Stevanato Group Corporation Information
6.3.2 Stevanato Group Description and Business Overview
6.3.3 Stevanato Group On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Stevanato Group On-Body Delivery System (OBDS) Product Portfolio
6.3.5 Stevanato Group Recent Developments/Updates
6.4 Enable Injections
6.4.1 Enable Injections Corporation Information
6.4.2 Enable Injections Description and Business Overview
6.4.3 Enable Injections On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Enable Injections On-Body Delivery System (OBDS) Product Portfolio
6.4.5 Enable Injections Recent Developments/Updates
6.5 Insulet
6.5.1 Insulet Corporation Information
6.5.2 Insulet Description and Business Overview
6.5.3 Insulet On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Insulet On-Body Delivery System (OBDS) Product Portfolio
6.5.5 Insulet Recent Developments/Updates
6.6 Ypsomed
6.6.1 Ypsomed Corporation Information
6.6.2 Ypsomed Description and Business Overview
6.6.3 Ypsomed On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Ypsomed On-Body Delivery System (OBDS) Product Portfolio
6.6.5 Ypsomed Recent Developments/Updates
6.7 Bexson
6.6.1 Bexson Corporation Information
6.6.2 Bexson Description and Business Overview
6.6.3 Bexson On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bexson On-Body Delivery System (OBDS) Product Portfolio
6.7.5 Bexson Recent Developments/Updates
6.8 Nemera
6.8.1 Nemera Corporation Information
6.8.2 Nemera Description and Business Overview
6.8.3 Nemera On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Nemera On-Body Delivery System (OBDS) Product Portfolio
6.8.5 Nemera Recent Developments/Updates
6.9 BD Medical
6.9.1 BD Medical Corporation Information
6.9.2 BD Medical Description and Business Overview
6.9.3 BD Medical On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BD Medical On-Body Delivery System (OBDS) Product Portfolio
6.9.5 BD Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 On-Body Delivery System (OBDS) Industry Chain Analysis
7.2 On-Body Delivery System (OBDS) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 On-Body Delivery System (OBDS) Production Mode & Process
7.4 On-Body Delivery System (OBDS) Sales and Marketing
7.4.1 On-Body Delivery System (OBDS) Sales Channels
7.4.2 On-Body Delivery System (OBDS) Distributors
7.5 On-Body Delivery System (OBDS) Customers
8 On-Body Delivery System (OBDS) Market Dynamics
8.1 On-Body Delivery System (OBDS) Industry Trends
8.2 On-Body Delivery System (OBDS) Market Drivers
8.3 On-Body Delivery System (OBDS) Market Challenges
8.4 On-Body Delivery System (OBDS) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
